This website uses cookies
Read our Privacy policy and Terms of use for more information.
Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
May 29, 2026
•
1 min read
Afrezza, the only inhalable mealtime insulin, is now available to children and adolescents signifying a step forward in pediatric diabetes care
A deep dive at the pros and cons of bi-hormonal pumps, how they work, and the two currently in-development by Beta Bionics and Inreda.
May 27, 2026
Watch the recording of our live Q&A where we dig into all the top CGMs from their pros and cons and unique features, to reliability and durability.
An estimated 7 million pods fall within the scope of this correction, in the U.S. and international markets, representing about 8.5% of 2025 global Pod production.
2 min read
Abbott's new Libre Duo sensors measure ketones and glucose levels simultaneously, and will be available in select European countries in late-2026.
May 26, 2026
The timeline reflects recent FDA feedback and manufacturing progress, with pharmacy access, CGM compatibility, and no recharging required at launch.